DeepMed Research

Chloride ion

Generic Name: Chloride ion

Drug Type: Small Molecule

Chemical Formula: Cl

CAS Number: 16887-00-6

Unique Ingredient Identifier: Q32ZN48698

Clinical Trials

Preventive Sodium Lactate and Traumatic Brain Injury

Phase 2

Completed

Conditions: Head Trauma

Interventions: Drug: isotonic sodium chloride
Drug: half molar sodium lactate

First Posted Date: 2009-10-15

Last Posted Date: 2011-07-12

Lead Sponsor: Institut d'Anesthesiologie des Alpes Maritimes

Target Recruit Count: 60

Registration Number: NCT00995683

Locations: 🇫🇷
Institut d'Anesthesiologie des Alpes maritimes, Nice, France

Erythropoietin in Traumatic Brain Injury (EPO-TBI)

Phase 3

Completed

Conditions: Traumatic Brain Injury

Interventions: Drug: Epoetin Alfa
Drug: Sodium Chloride 0.9%

First Posted Date: 2009-10-01

Last Posted Date: 2016-07-26

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 606

Registration Number: NCT00987454

Locations: 🇦🇺
Royal Perth Hospital, Perth, Western Australia, Australia
🇦🇺
The Royal Melbourne Hospital, Melbourne, Victoria, Australia
🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

and more 25 locations

A Study of the Efficacy and Safety of 2PX in Patients With Pain Due to Osteoarthritis of the Knee

Phase 3

Conditions: Pain
Osteoarthritis

Interventions: Drug: strontium chloride hexahydrate
Drug: Placebo

First Posted Date: 2009-08-07

Last Posted Date: 2010-03-24

Lead Sponsor: Smerud Medical Research International AS

Target Recruit Count: 300

Registration Number: NCT00954629

Locations: 🇵🇱
Site in Bialystok, Bialystok, Poland
🇵🇱
Site in Kraków, Kraków, Poland
🇷🇺
Site in St-Petersburg, St-Petersburg, Russian Federation

and more 11 locations

AXIS 2: AX200 for the Treatment of Ischemic Stroke

Phase 2

Completed

Conditions: Acute Ischemic Stroke

Interventions: Biological: Filgrastim
Drug: Sodium chloride solution

First Posted Date: 2009-06-25

Last Posted Date: 2011-12-13

Lead Sponsor: Sygnis Bioscience GmbH & Co KG

Target Recruit Count: 328

Registration Number: NCT00927836

Locations: 🇧🇪
Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
🇧🇪
Universitair Ziekenhuis Gent, Gent, Belgium
🇨🇿
Faculty Hospital 1, Plzeň - Lochotín, Czech Republic

and more 53 locations

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

Phase 3

Terminated

Conditions: Breast Cancer

Interventions: Biological: Placebo of tecemotide (L-BLP25) and Hormonal Treatment
Biological: Tecemotide (L-BLP25) and Hormonal Treatment
Drug: cyclophosphamide
Drug: sodium chloride (NaCl)

First Posted Date: 2009-06-22

Last Posted Date: 2014-07-24

Lead Sponsor: EMD Serono

Target Recruit Count: 16

Registration Number: NCT00925548

Locations: 🇿🇦
Research Site, Johannesburg, South Africa

Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis

Phase 4

Completed

Conditions: Hepatic Encephalopathy

Interventions: Drug: Albumin
Drug: Sodium chloride 0.9%

First Posted Date: 2009-04-23

Last Posted Date: 2012-12-17

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 56

Registration Number: NCT00886925

Locations: 🇪🇸
Hospital de Sant Pau, Barcelona, Spain
🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain
🇪🇸
Parc Tauli, Sabadell, Barcelona, Spain

and more 1 locations

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson's Disease

Interventions: Drug: piclozotan
Drug: 0.9% sodium chloride (normal saline)

First Posted Date: 2008-02-26

Last Posted Date: 2021-03-11

Lead Sponsor: Daiichi Sankyo

Target Recruit Count: 27

Registration Number: NCT00623363

Locations: 🇺🇸
Suny Downstate Medical Center, Brooklyn, New York, United States
🇺🇸
UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇬🇹
Hospital Multimedica, Guatemala, Guatemala

and more 4 locations

Rapid Diagnosis of Pulmonary Tuberculosis

Not Applicable

Conditions: Tuberculosis

Interventions: Drug: Salbutamol
Drug: Sodium chloride 5%

First Posted Date: 2008-02-06

Last Posted Date: 2012-07-24

Lead Sponsor: University of Cape Town

Target Recruit Count: 600

Registration Number: NCT00608790

Locations: 🇿🇦
University of Cape Town, Cape Town, South Africa

2PX (Topical Strontium Chloride Hexahydrate) in Patients With Post-Amputation Stump Pain.

Phase 2

Completed

Conditions: Amputation Stumps
Pain

Interventions: Drug: Strontium chloride hexahydrate
Drug: Placebo

First Posted Date: 2008-01-11

Last Posted Date: 2008-01-11

Lead Sponsor: SantoSolve AS

Target Recruit Count: 22

Registration Number: NCT00592098

Locations: 🇳🇴
Smerud Investigator site 1, Oslo, Norway

Arterial pH and Total Body Nitrogen Balances in APD

Phase 4

Completed

Conditions: End-stage Renal Disease

Interventions: Drug: ammonium chloride or sodium citrate/citric acid
Drug: Sodium citrate/citratic acid

First Posted Date: 2008-01-04

Last Posted Date: 2017-09-05

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 8

Registration Number: NCT00586131

Locations: 🇺🇸
Los Angeles Biomedical Research Institute, Torrance, California, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy